Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)

被引：35
|
作者：
Abedi, Farshad [1 ]
Rezaee, Ramin [2 ,3 ]
Karimi, Gholamreza [1 ,4 ]
机构：
[1] Mashhad Univ Med Sci, Inst Pharmaceut Technol, Pharmaceut Res Ctr, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Clin Res Unit, Fac Med, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Mashhad, Razavi Khorasan, Iran
来源：
PHARMACOLOGICAL RESEARCH | 2020年 / 156卷
关键词：
D O I：
10.1016/j.phrs.2020.104808
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease:COVID-19
    Rohilla, Suman
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (01) : 12 - 26
  • [2] Highlight of severe acute respiratory syndrome coronavirus-2 vaccine development against COVID-19 pandemic
    Liu, Cheng-Hsuan
    Huang, Hsuan-Yang
    Tu, Yung-Fang
    Lai, Wei-Yi
    Wang, Chia-Lin
    Sun, Jun-Ren
    Chien, Yueh
    Lin, Tzu-Wei
    Lin, Yi-Ying
    Chien, Chian-Shiu
    Huang, Chih-Heng
    Chen, Yuh-Min
    Huang, Pin-, I
    Wang, Fu-Der
    Yang, Yi-Ping
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (01) : 9 - 13
  • [3] Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19
    Li, Qian
    Zheng, Xiao-Shuang
    Shen, Xu-Rui
    Si, Hao-Rui
    Wang, Xi
    Wang, Qi
    Li, Bei
    Zhang, Wei
    Zhu, Yan
    Jiang, Ren-Di
    Zhao, Kai
    Wang, Hui
    Shi, Zheng-Li
    Zhang, Hui-Lan
    Du, Rong-Hui
    Zhou, Peng
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 2571 - 2577
  • [4] Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Choudhry, Namrta
    Zhao, Xin
    Xu, Dan
    Zanin, Mark
    Chen, Weisan
    Yang, Zifeng
    Chen, Jianxin
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (22) : 13205 - 13227
  • [5] Comparison of severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccine side effects by age groups
    Tosun, Fadime
    Bulbul, Mehmet
    Tosun, Ismail
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (04): : 476 - 481
  • [6] Effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus (COVID-19) vaccination on male fertility
    Chen, Fei
    Zhang, Yunfei
    Zhang, Yingze
    Li, Yuqi
    Ma, Jiao
    Qin, Yining
    Deng, Shuwen
    Zhang, Yuhan
    Wang, Deyang
    Wang, Haiying
    Lin, Juan
    SEXUAL HEALTH, 2024, 21 (02)
  • [7] Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
    Cao, Yu-chen
    Deng, Qi-xin
    Dai, Shi-xue
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 35
  • [8] Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19
    Byard, Roger W.
    Hunsaker, John
    Tsokos, Michael
    FORENSIC SCIENCE MEDICINE AND PATHOLOGY, 2020, 16 (04) : 745 - 745
  • [9] Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19
    Roger W. Byard
    John Hunsaker
    Michael Tsokos
    Forensic Science, Medicine and Pathology, 2020, 16 : 745 - 745
  • [10] Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)
    Khunti, Sachin
    Khunti, Nitisha
    Seidu, Samuel
    Khunti, Kamlesh
    DIABETES OBESITY & METABOLISM, 2020, 22 (10): : 1942 - 1945
12345